Bryan R. Leigh

2.7k total citations
49 papers, 2.1k citations indexed

About

Bryan R. Leigh is a scholar working on Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bryan R. Leigh has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bryan R. Leigh's work include Lymphoma Diagnosis and Treatment (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Bryan R. Leigh is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Bryan R. Leigh collaborates with scholars based in United States, Switzerland and Australia. Bryan R. Leigh's co-authors include Weibo Cai, Yunan Yang, Thomas E. Witzig, Hao Hong, Gregory A. Wiseman, Todd E. Barnhart, Jonathan W. Engle, David R. Gandara, William D. Erwin and Richard Sparks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bryan R. Leigh

49 papers receiving 2.1k citations

Peers

Bryan R. Leigh

RNMI

PRM

ONCOL

PFM

Stewart Kroll United States

Baldassarre Stea United States

Melanie C. Smitt United States

George H. Hinkle United States

Hans‐Juergen Wester Germany

Mirco Bartolomei Italy

Jamie Honeychurch United Kingdom

Pratik S. Multani United States

Denise Regan United States

Serengulam V. Govindan United States

Stewart Kroll United States

Bryan R. Leigh

1.8k ×2.2

RNMI

945 ×1.2

PRM

1.3k ×1.6

ONCOL

1.5k ×2.7

PFM

596 ×1.6

Citations per year, relative to Bryan R. Leigh Bryan R. Leigh (= 1×) peers Stewart Kroll

Countries citing papers authored by Bryan R. Leigh

Since Specialization

Citations

This map shows the geographic impact of Bryan R. Leigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan R. Leigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan R. Leigh more than expected).

Fields of papers citing papers by Bryan R. Leigh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan R. Leigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan R. Leigh. The network helps show where Bryan R. Leigh may publish in the future.

Co-authorship network of co-authors of Bryan R. Leigh

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan R. Leigh. A scholar is included among the top collaborators of Bryan R. Leigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan R. Leigh. Bryan R. Leigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gordon, Michael S., Lee S. Rosen, David S. Mendelson, et al.. (2012). A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Investigational New Drugs. 31(3). 714–723. 26 indexed citations

Yang, Yunan, Yin Zhang, Hao Hong, et al.. (2011). In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis. European Journal of Nuclear Medicine and Molecular Imaging. 38(11). 2066–2076. 31 indexed citations

Theuer, Charles P., Bryan R. Leigh, Pratik S. Multani, R. S. Allen, & Bertrand C. Liang. (2004). Radioimmunotherapy of non-Hodgkin’s lymphoma: Clinical development of the Zevalin regimen. PubMed. 10. 265–295. 15 indexed citations

Wiseman, Gregory A., et al.. (2003). Additional Radiation Absorbed Dose Estimates for Zevalin™ Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 253–258. 20 indexed citations

Wiseman, Gregory A., Bryan R. Leigh, William D. Erwin, et al.. (2003). Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 165–178. 25 indexed citations

Younes, Anas, Kandasamy Hariharan, R. S. Allen, & Bryan R. Leigh. (2003). Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma. Clinical Lymphoma. 3(4). 257–259. 27 indexed citations

Wiseman, Gregory A., Bryan R. Leigh, William D. Erwin, et al.. (2002). Radiation dosimetry results for zevalin radioimmunotherapy of rituximab-refractory non-hodgkin lymphoma. Cancer. 94(S4). 1349–1357. 73 indexed citations

DeNardo, Sally J., Lawrence E. Williams, Bryan R. Leigh, & Richard L. Wahl. (2002). Choosing an optimal radioimmunotherapy dose for clinical response. Cancer. 94(S4). 1275–1286. 20 indexed citations

Hong, Angela, et al.. (2001). Induction of interleukin-6 and oncostatin M by radiation in Kaposi’s sarcoma cell lines. International Journal of Radiation Oncology*Biology*Physics. 50(2). 533–540. 7 indexed citations

10.

DeNardo, Sally J., Peter Burke, Bryan R. Leigh, et al.. (2000). Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 71–79. 44 indexed citations

11.

Leigh, Bryan R., Peter Burke, Angela Hong, et al.. (1999). Preclinical Evaluation of Chimeric L6 Antibody for the Treatment of Kaposi's Sarcoma with Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 14(2). 113–119. 2 indexed citations

12.

Leigh, Bryan R., David R. Gandara, John J. Crowley, et al.. (1999). Summary of the proceedings of the United States–Japan lung cancer clinical trials summit: San Francisco, CA, 20–22 November, 1998. Lung Cancer. 24(3). 181–191. 3 indexed citations

13.

Leigh, Bryan R. & Derick Lau. (1998). Severe Esophageal Toxicity After Thoracic Radiation Therapy for Lung Cancer Associated With the Human Immunodeficiency Virus. American Journal of Clinical Oncology. 21(5). 479–481. 10 indexed citations

14.

Seaward, Samantha A., et al.. (1998). Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 42(5). 1055–1062. 66 indexed citations

15.

Leigh, Bryan R., Edward C. Larkin, & R. L. Scotte Doggett. (1997). Solitary Extramedullary Plasmacytoma Five Years after Successful Cardiac Transplantation:. American Journal of Clinical Oncology. 20(5). 467–470. 20 indexed citations

16.

Shui, Chaoxiang, et al.. (1995). Effects of stem cell factor on the growth and radiation survival of tumor cells.. PubMed. 55(15). 3431–7. 4 indexed citations

17.

Leigh, Bryan R., Baldassarre Stea, J. Robert Cassady, John M. Kittelson, & T. C. Cetas. (1994). Clinical hyperthermia with a new device: The current sheet applicator. International Journal of Radiation Oncology*Biology*Physics. 30(4). 945–951. 7 indexed citations

18.

Buatti, John M., Paul M. Harari, Bryan R. Leigh, & J. Robert Cassady. (1994). Radiation-Induced Angiosarcoma of the Breast. American Journal of Clinical Oncology. 17(5). 444–447. 45 indexed citations

19.

Leigh, Bryan R., et al.. (1993). Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. International Journal of Radiation Oncology*Biology*Physics. 27(4). 855–862. 34 indexed citations

20.

Leigh, Bryan R., et al.. (1993). Radiation therapy for the palliation of multiple myeloma. International Journal of Radiation Oncology*Biology*Physics. 25(5). 801–804. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact